USPTO serial 78605127
ARROW PHARMACEUTICALS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SINGLETON, RUDY
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ARROW PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mississauga, Ontario, CA
Mississauga, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sally M. Abel, Esq.
SALLY M ABEL ESQ TERFENWICK & W LLP801 CALIFORNIA ST SILICON VALLEY CENMOUNTAIN VIEW, CA 94041-2008Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, preparations for the prevention and treatment of cancers; pharmaceutical preparations, namely, platelet stimulating factors; pharmaceutical cardiovascular preparations; Pharmaceutical preparations for the treatment of cardiovascular disease, urological disorders, gastrointestinal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and respiratory diseases, fungal disorders; pharmaceutical preparations, namely, anti-inflammatory analgesics; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations; Pharmaceutical preparations for the treatment of diabetes, cancer; pharmaceutical preparations comprising protein kinase or phosphatase; pharmaceutical preparations affecting signal transduction pathways; reagents for scientific or medical research use; scientific and medical compounds, namely protein kinases and phosphatases; Pharmaceutical preparations for the prevention and/or treatment of cancer, carcinomas and sarcomas; pharmaceutical preparations for the prevention and/or treatment of tumours of any description; Pharmaceutical preparations for the treatment of pains, fever, angina, otorhinolaryngology, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; anaesthetics, analgesics, frostbite salve for pharmaceutical purposes, haemorrhoid preparations, pharmaceutical preparations for the treatment of headaches, salts for medicated baths, mouthwashes for medical purposes, medicinal mud, bracelets for medical purposes, tranquilizers, sedatives, tobacco free cigarettes for medical purposes, medicines for alleviating constipation, contraceptives chemicals, radiological contrast substances for medical purposes, corn remedies, cotton for medical purposes, diagnostic preparations for medical purposes, drugs for the treatment of pain, fever, angina otorhinolaryngology, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses, mineral water for medical purposes; Pharmaceutical preparations for the treatment of smooth muscle disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, tremors, namely, spasmodic smooth, striated or cardiac muscles; and pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; muscle dystonias, nerve disorders, spasmodic striated, smooth or cardiac muscles; pharmaceutical preparations for the treatment of cerebral palsy; Pharmaceutical preparations and substances, namely anti-infective, anti-bacterials, antibiotics, antivirals, antidiabetic preparations, cardiovascular preparations, hemostatic agents, pharmaceutical preparations and substances for the treatment of cancer, HIV, obesity and respiratory and urologic disorders and diseases; pharmaceutical preparations and substances for the treatment of acute ischemic stroke and traumatic brain injury (TBI), cerebral vasodilators; Prescription pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, peripheral nervous system, cardiovascular system, gastro-intestinal system; prescription pharmaceutical preparations and substances for use in pain control, anaesthesia, oncology; prescription pharmaceutical preparations and substances for the treatment and prevention of diabetes | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 31, 2007 | MAB4 | ABANDONMENT NOTICE MAILED - INTER PARTES DECISION | — |
| Jan 31, 2007 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Jan 31, 2007 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Oct 24, 2006 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Sep 28, 2006 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 29, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 9, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 3, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 30, 2006 | ALIE | ASSIGNED TO LIE | — |
| Jun 24, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 17, 2005 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 5, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 22, 2005 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 15, 2005 | NWAP | NEW APPLICATION ENTERED | — |